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to the way in which ethical issues are addressed in
jointly conducted research. One of us (EMM) reported
previously in this journal of our efforts to better under-
stand the ethics needs of investigators and ethics review
committees at Indiana University and at Moi University
(Sidle et al., 2006). In this paper, we focus on a specific
topic in international research ethics: the involvement
of children.
Multinational research in developing countries can
yield a number of ethical challenges as researchers
attempt to avoid exploitation and to build true collabora-
tive partnership (Emanuel et al., 2004). While informed
consent is widely accepted as an ethical and legal
requirement of clinical research, cultural and language
differences add an additional level of difficulty
(Emanuel et al., 2004). Obtaining informed consent for
research involving children raises special, additional
concerns, as children are generally not considered capa-
ble of informed consent. Research within this vulnera-
ble population thus requires adults to provide consent
for the children and prompts consideration of addi-
tional measures, such as obtaining children’s assent. In
this paper, we seek to describe and analyze particular
ethical issues related to implementing pediatric assent
policies within clinical research in western Kenya.
While these challenges are of immediate relevance to
the AMPATH clinical care system and research net-
work, we also seek to illuminate the issues that may
arise for conducting pediatric research in other
resource-limited settings.
A Case Study from Western Kenya
Children infected with Human Immunodeficiency
Virus (HIV) require antiretroviral therapy (ART) in
order to stay alive and to fight their HIV infection.
Through the AMPATH system of clinics in rural and
urban Western Kenya, over 3,300 HIV-infected children
currently receive free ART (Figure 1). Despite the wide-
spread, international use of ART, the proper dosing of
these medicines in children has not been well studied
(Havens & Gibb, 2007). Moreover, because 90% of
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SINCE 2001, THE INDIANA UNIVERSITY SCHOOL ofMedicine has partnered with the Moi UniversitySchool of Medicine, one of three medical schools inKenya, to provide care for over 85,000 adults and
children in Western Kenya who are infected with Human
Immunodeficiency Virus (HIV). This collaboration,
recently renamed the USAID–Academic Model
Providing Access To Healthcare (AMPATH) Partnership,
has a tripartite mission to provide clinical care, to
enhance medical education, and to conduct research. A
key component of this collaboration has been attention
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HIV-infected children live in Africa (UNICEF, 2007),
many in resource-limited settings where children are
more likely to be malnourished, it is especially impor-
tant to find out whether the drug doses need to be
adjusted for children who are malnourished. To address
this knowledge gap, AMPATH pediatricians designed a
study protocol to measure the pharmacokinetics or
metabolism of nevirapine, one first-line antiretroviral
medication for HIV-infected pediatric patients. In this
study protocol, researchers proposed to evaluate both
the nevirapine pharmacokinetics and the nutritional sta-
tus of HIV-infected children ages three to thirteen years,
who were initiating antiretroviral therapy with nevirap-
ine. The objective of this research was to provide a
pharmacokinetics model for nevirapine in children that
could guide pediatric dosing for children in sub-
Saharan Africa, with attention to how this dosing might
need to change in the setting of malnutrition.
The pediatric nevirapine pharmacokinetics study
required the children to stay overnight in the hospital
on two occasions. During these two hospitalizations,
the children would have five small blood samples
drawn, from which the researchers would measure the
level of the drug in the child’s blood, as well as the
child’s nutritional status. This protocol was the most
invasive research investigation proposed to date for
children within the AMPATH research collaboration.
For example, no previous prospective research studies of
children within AMPATH required overnight hospital-
ization or even the drawing of blood exclusively for the
purposes of research.
Key Issues Arising from the Case
As with most international collaborations between
investigators located in different countries, it is custom-
ary (and in some countries required) that protocols be
reviewed and approved by ethics review bodies in each
country. Within the IU-Kenya research collaboration, study
protocols must be reviewed and approved by both the
local IRB in Indianapolis at Indiana University–Purdue
University Indianapolis (IUPUI IRB) and the local
Kenyan Institutional Research Ethics Committee of the
Moi University School of Medicine (MU IREC). The
requirement for joint review has been part of the stan-
dard operating procedures of these committees, both of
which have federal-wide assurances on file with the U.S.
Office for Human Research Protection and as such are
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FIG. 1. Locations of the AMPATH HIV Care System in Western Kenya.
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required to be familiar with (and to comply with) the
U.S. federal policy for the protection of human subjects
(also called the “Common Rule,” found at 45 CFR 46,
Subpart A). Both review bodies are also familiar with
the additional protections for research involving chil-
dren (found at 45 CFR 46, Subpart D). We also note that
nothing in these regulations stipulate how joint review
will occur (e.g., whether review is done sequentially or
simultaneously, whether one has veto power over the
other, etc.). These are matters to be worked out on the
ground (Sidle et al., 2006). 
Given this brief background, we next describe the
communication with each review committee, focusing
more on the Kenyan communications, since these may
be of more interest to readers less familiar with non-U.S.
ethics review. We will then provide a more detailed
assessment of what we learned.
Communication with the Indianapolis 
Review Board
The IUPUI IRB typically classifies protocols and what is
required for consent or assent based on the risks to sub-
jects compared to the potential benefits. By their pub-
lished criteria, they considered the protocol of minimal
risk to the pediatric subjects since the pediatric pharma-
cokinetics study required only a series of blood draws,
but no other invasive procedures. Based on this degree
of risk, the standard IUPUI institutional policy is to
obtain written assent for children seven years of age and
older. The national and international guidelines on
which this policy is based are described in more detail
later in the paper. In addition, the study participants had
the potential to experience direct benefits in terms of
drug dosing adjustments based on their individual char-
acteristics and drug levels. These data would not be
available in routine AMPATH clinical care. Since the
investigators in the collaborative partnership had not
previously conducted pediatric research of this kind in
Kenya, one of the principal investigators queried mem-
bers of the IUPUI IRB related to the issue of pediatric
assent in this setting. In written communication prior to
the submission of the full IRB protocol, the IUPUI IRB
recommended that the protocol follow the standard
IUPUI institutional policy for pediatric assent, where
written assent is obtained for children seven years of age
and older. 
The AMPATH researchers working on this project
agreed to try to introduce a requirement for pediatric
assent as part of the protocol to investigate pediatric
pharmacokinetics in Kenya. Factors influencing this
original decision included the recommendations of the
IUPUI IRB, the desire to introduce specific protections
for the vulnerable pediatric population in the Kenya
research setting, and the specific features of the trial—
where direct benefit was possible, but not certain, and
where the children would be required to undergo fairly
burdensome procedures that included two nights in the
hospital and a series of blood draws. The researchers
designed the original study protocol to require that ver-
bal, witnessed assent be obtained for children seven
years of age and older.  
This protocol was sent to the IUPUI IRB and MU
IREC for review in tandem, and was reviewed by the
IUPUI IRB first. The IUPUI IRB approved the protocol
with no recommended revisions to the portion of the
protocol involving pediatric assent or informed consent. 
Communication with the Eldoret 
Review Board
The MU IREC approved the study, but communicated
that much deliberation went into the approval of the
protocol. There was no prior history of obtaining pedi-
atric assent in research studies approved by MU IREC,
so the recommendation of the IUPUI IRB presented a
novel concept for consideration, and one that was met
with some surprise and concern. Concerns were
expressed about whether children under the age of four-
teen had the right and the capacity to make autonomous
decisions, with particular concern regarding the ability
of children at this age to reason through the decision-
making process necessary to consent. In some parts of
Kenya, children are not viewed as autonomous decision
makers and may have little experience with exercising
autonomy. However, the view of the child, and also the
child’s ability to participate in this process, were thought
to vary widely based on whether the child was from an
urban or rural part of the country and the degree to
which the child and parents had been educated (and,
potentially, Westernized). Citing steadily changing and
more progressive views of the Kenyan child’s capacity
and experiences, some thought that the society had
reached a place where pediatric assent should be sought
and valued.
Furthermore, there were logistic questions: In what
language or languages would the assent procedures take
place given that many children learn a tribal language
as their primary language, followed by the more uni-
versal Kiswahili, and then may learn only English in
school? Would written assent or verbal assent be used?
For Kenyan adults, signing a document with words that
you cannot read is considered inappropriate, even if the
document has been read aloud in full (Sidle et al., 2006).
Pediatric Assent in Western Kenya 5
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Thus, previous studies in this setting have used the sig-
natures of two witnesses to document verbal consent.
Should a study in children employ the same techniques?
Finally, would age criteria or some other criteria be used
to determine for which children assent was required?
After considering these issues, the MU IREC
approved a study protocol in which verbal, witnessed
informed consent would be obtained from a parent or
guardian of the participating child and that verbal, wit-
nessed assent would be obtained for children seven
years of age and older. Because this same protocol had
previously received approval by the IUPUI IRB, the MU
IREC discussion was not conveyed to the IUPUI IRB.
As we know, the mere outcomes of IRB review are
a necessary but not a sufficient component for fully
understanding overall research decision making in the
international environment. Below we describe some of
the key issues that help to explain some of the unique
feature of these deliberations.
Pediatric Assent in Multinational Research
Our case revealed many important differences in both
ethical and procedural issues in international research
collaborations. The review committee from the spon-
soring country (the IUPUI IRB) recommended follow-
ing rules that written pediatric assent for children seven
years of age and older must be obtained. The ethics
review committee from the country in which the
research would be conducted (MU IREC) had not pre-
viously implemented pediatric assent for children under
fourteen years and questioned its appropriateness. As
such, the protocol highlights raises a number of key
questions facing all researchers in international collabo-
rative studies: How should consensus be reached when
clear consensus may not be present within a single
country? When collaborating partners have different
ideas about appropriate ethical standards—in this case,
about the need to obtain pediatric assent from children
over seven years of age—how should those differences
be resolved? 
To move toward answering these questions, we first
consider the state of pediatric assent and its implemen-
tation in both settings. We then examine the interna-
tional guidelines for consent and assent in pediatric
research subjects. Next we discuss the particular ethical
challenges related to the concept of pediatric assent, and
then the challenges for pediatric assent specific to the
Kenyan context. Finally, working from the considera-
tion of the guidelines and the nuances of the ethical
issues for pediatric assent in international research, we
propose a way forward in approaching pediatric assent
for research subjects within the AMPATH collaborative
research program in western Kenya that may apply to
other multinational research partnerships.
Current State of Pediatric Assent in Kenya
Although it was a new issue for our research collabora-
tion, consideration of pediatric assent has been docu-
mented in other research settings in Kenya. In a
qualitative study examining opinions of Kenyan com-
munity members related to informed consent for
research, Molyneux et al. asked community focus
groups whether consent should be sought from Kenyan
children from whom blood samples would be requested
(Molyneux et al., 2005b). They reported that all of the
groups “reacted with surprise” to the question of consid-
ering consent for children, with “general agreement that
children should not be asked,” and they further speci-
fied that investigators should not consider asking chil-
dren aged ten to twelve years (Molyneux et al., 2005b).
The study participants reported concerns that the chil-
dren could not “reason things out” or understand why
the samples were needed, and they felt that fear of pain
would be the children’s only consideration (Molyneux
et al., 2005b). Even for children ages ten to thirteen
years, the Kenyan community members felt that the
researchers should discuss the project directly only with
the parents, and then the parents could relay the infor-
mation to the children (Molyneux et al., 2005b). We
could not find any literature documenting how often or
in what manner pediatric assent is incorporated in bio-
medical research in Kenya or in sub-Saharan Africa. 
Current State of Pediatric Assent in the United States
In the United States, research on pediatric assent exists,
but this research suggests that pediatric assent is imple-
mented in very different ways from one locality to
another. United States federal regulations for the protec-
tion of human subjects state that, when the IRB deter-
mines that assent is required, the IRB shall determine
whether and how assent must be documented (45 CFR
46, 404). In a study reviewing pediatric assent and con-
sent documents approved by 55 local IRBs in 23 states
reviewing three standardized, multicenter clinical trial
protocols involving children, Kimberley et al. found that
the requirements for assent differed dramatically among
the institutions (Kimberly et al., 2006). Working from
the same standardized research protocols, 83 percent
included some method for documenting child partici-
pant assent. Of 69 sets of approved forms, 33 included a
line for assent on the informed permission or consent
6 R. Vreeman, W. Nyandiko, E. Meslin
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form, while 35 required a separate, simplified form for
pediatric assent (Kimberly et al., 2006). Thirty-one
forms specified an age range at which pediatric assent
needed to be secured, but the specified age ranges var-
ied considerably (Kimberly et al., 2006). While some
IRBs mandated obtaining pediatric assent from six-
year-olds, others established the age to obtain assent as
late as fifteen years (Kimberly et al., 2006). These exam-
ples compare with the policy of the IUPUI IRB, which
typically requires written pediatric assent be obtained
from children seven years and older (IUPUI, 2008).
Professional, National, and International Oversight on 
Assent and Consent with Pediatric Research Subjects
The moral foundation for informed consent and assent
involving children in U.S. regulations was well
described by the National Commission in its report
“Research on Children” (National Commission, 1977)
and in the Belmont Report (National Commission,
1979). The relevant principle in Belmont is respect for
persons:  
The principle of respect for persons thus divides into
two separate moral requirements: the requirement
to acknowledge autonomy and the requirement to
protect those with diminished autonomy.
While there is much about Belmont that is applicable
to children, there are still areas of disagreement
(Childress, Meslin, & Shapiro, 2005). For example, this
principle could be interpreted to support separating
children into two categories: older, more mature chil-
dren with the capacity to be autonomous versus very
young children who should be protected and from
whom assent is not required (Wendler & Shah, 2003).
Alternatively, others interpret this principle to require
that all individuals, even very young children, partici-
pate in decision making to the extent that they are able
(Nelson & Reynolds, 2003). 
A review of selected guidelines reveals some impor-
tant variations in the details of how assent, capacity, or
age are defined. U.S. regulations for the protection of
human subjects include special protections for children
(45 CFR 46, Subpart D) which define children as “per-
sons who have not attained the legal age for consent
to treatments or procedures involved in the research,
under the applicable law of the jurisdiction in which
the research will be conducted” and assent as “a child’s
affirmative agreement to participate in research,” noting
that “mere failure to object should not, absent affirma-
tive agreement, be construed as assent” (45 CFR
46.406[a][b]). For research not involving greater than
minimal risk, federal regulations permit investigators to
involve children only if the IRB finds that “adequate
provisions are made for soliciting the assent of the chil-
dren and the permission of their parents or guardians”
(45 CFR 46.404). The responsibility of determining
when and how pediatric assent will be obtained is left to
the IRB (Ungar, Joffe, & Kodish, 2006); the IRB can
determine “whether and how assent must be docu-
mented”(45 CFR 46.404 and 408), leaving the process
less defined than documenting informed consent in
adults. While the regulations do not specify an age at
which pediatric assent is recommended, the National
Commission recommended obtaining assent for chil-
dren ages seven years and older, with the objection of
a child of any age considered as binding (National
Commission, 1977).  
The American Academy of Pediatrics (AAP)
Committee on Bioethics recommends that pediatric
assent should include helping the patient achieve a
developmentally appropriate awareness of their condi-
tion, telling the patient what to expect, making a clinical
assessment of the patient’s understanding, and “solicit-
ing an expression of the patient’s willingness to accept
the proposed care” (Committee on Bioethics, American
Academy of Pediatrics, 1995). These guidelines do not
distinguish between assent for research and assent for
treatment, nor do they define what is “developmentally
appropriate” and how exactly the patient’s willingness
should be solicited or documented. For pediatric partic-
ipation in studies of drugs, the AAP endorses that seven
years be used as the age from which assent for research
must be obtained (Committee on Drugs, American
Academy of Pediatrics, 1995).  
In Kenya, the Guidelines for the Ethical Conduct of
Biomedical Research Involving Human Subject pub-
lished by the Kenya National Council for Science and
Technology support respect for the dissent of pediatric
research subjects, stating that when “the child refuses
to participate in the research, that refusal must be
respected unless there’s no other medical alternative
from which the child could benefit” (Kenya NCST,
2004). While these guidelines do not specifically man-
date pediatric assent, the clear emphasis on respecting a
child’s dissent might suggest a similar position. These
guidelines could also be interpreted to indicate willing-
ness to rely on implied assent, assuming that active dis-
sent was not voiced. 
Several international guidelines support the require-
ment for pediatric assent, while continuing to vary in
definition and ages included. The guidelines from the
Council for International Organisations of Medical
Science (CIOMS) require the investigator to ensure that
Pediatric Assent in Western Kenya 7
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“the willing cooperation of the child should be sought,
after the child has been informed to the extent that the
child’s maturity and intelligence permit” and that “a
deliberate objection by a child to taking part in research
should always be respected even if the parents have
given permission, unless the child needs treatment that
is not available outside the context of research, the inves-
tigational intervention shows promise of therapeutic
benefit, and there is no acceptable alternative therapy”
(CIOMS, 2002). The CIOMS guidelines do note that the
age of legal consent “differs substantially” among coun-
tries, and they leave latitude based on local jurisdiction
though they generally propose obtaining pediatric
assent at twelve or thirteen years of age and beyond
(CIOMS, 2002). 
The World Medical Association’s Declaration of
Helsinki, includes a more inclusive statement about the
need to procure pediatric assent: 
B25. When a potential research subject deemed
legally incompetent, such as a minor child, is able 
to give assent to decisions about participation in
research, the physician should seek that assent in
addition to the consent of the legally authorized rep-
resentative (World Medical Association, 2008).
Helsinki thus requires that investigators obtain pediatric
assent, but makes no qualifications about how this
might vary with age or about the methods to be used.  
Guidelines for gathering information from children
and adolescents in international settings jointly devel-
oped by the Population Council, Family Health
International, USAID, and UNICEF recommend
obtaining community-level consent from an advisory
board that includes children and adults before the activ-
ity may proceed (Schenk & Williamson, 2005). These
guidelines also recommend the use of an independent
advocate for children to represent the child’s views if
there is any doubt about whether the guardians have the
child’s best interests in mind. Other groups, such as
UNESCO (UNESCO, 2002) and the OECD (OECD,
2008) also have proposed guidelines that include assent
provisions for children, focusing particularly on genetics
studies.
Developmental Considerations Relevant 
to Pediatric Assent
Despite the ethical rationale for obtaining pediatric
assent and the prevalence of statements about pediatric
assent in national and international guidelines, imple-
mentation of pediatric assent in any context requires care-
ful consideration of a number of practical and theoretical
concerns. The details make a difference. For children,
several important considerations for pediatric assent are
linked to the child’s development. The age threshold set
for pediatric assent, factors affecting a child’s ability to
make decisions, and the specific vulnerabilities of pedi-
atric research subjects all merit reflection.
The age at which assent is sought has both practical
and theoretical implications. Practically speaking, set-
ting a chronological age at which assent must be
obtained allows clear direction for implementing an
assent process. However, as we note above, the age
thresholds set by IRBs can range widely across institu-
tions and across protocols (Kimberly et al., 2006), and
the validity of these age guidelines is open to question.
Obtaining assent at seven years of age and older is rela-
tively common, but the primary defense for this position
is the “Rule of Sevens” that originated in the 1300s
(Wendler, 2006). This rule states that children under
the age of seven lack the capacity to make their own
decisions, while children from seven to fourteen are
presumed not to have this capacity until proven other-
wise, and children over fourteen years of age are pre-
sumed to have decision-making capacity unless proven
otherwise (Wendler, 2006). Wendler has argued that the
long history of this “rule” does not necessarily mean it is
developmentally appropriate to use to determine pedi-
atric assent practices, nor does the rule even clearly sup-
port asking for assent after age seven (Wendler, 2006).
Moreover, studies of children’s understanding of clinical
trials provide evidence that the threshold should be set
at nine years or at eleven years (Tait, Voepel-Lewis, &
Malviya, 2003; Ondrusek et al., 1998).
In addition to the crucial concept of age, a number of
other factors can influence a child’s ability to give assent.
First, maturity may be a greater factor in the ability to
make decisions and weigh risks than chronological age
(Barfield & Church, 2005; Lewis, 1981). The psycholog-
ical state of the child, as well as the child’s particular
medical diagnosis, could impact their feelings of control
(Dorn, Susman, & Fletcher, 1995; Meaux & Bell, 2001).
The child’s role and relationships with others and the
perceived impact of disagreeing with important figures
can impact the assent process (Johnston, 2006; Broome
& Richards, 2003). In addition, factors such as who is
asked to obtain assent (Meaux & Bell, 2001) and
whether the child has previous experience with research
(Broome & Richards, 1998) can sway the child’s deci-
sion of assent or dissent without consideration of the
risks and benefits.
For pediatric assent, researchers must also consider
the particular vulnerabilities of the pediatric population
within research. Kipnis identified seven concepts of
8 R. Vreeman, W. Nyandiko, E. Meslin
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vulnerability in the pediatric research subject, including
children’s lack of capacity to make mature decisions,
being subject to the authority of others, and being defer-
ential in ways that mask underlying dissent (Kipnis,
2003). While these vulnerabilities in some ways under-
pin the need to support and protect pediatric assent,
they also can impinge on the assent process itself,
undermining the extent to which assent provides real
protection, and instead creating a sense of false security
that children are protected merely because one obtained
assent. Assent may not be legitimate if children’s capac-
ities, roles, and relationships undermine their ability to
provide independent assent.
Cultural Context for Pediatric Assent in Kenya
Within international research settings, particular threats
to informed consent may arise. These threats include
significant differences in education between investiga-
tors and community members (Shapiro & Meslin,
2001); mismatches in the understanding, value, and pri-
orities of health and illness (Fairhead, Leach, & Small,
2006); and limited access to quality health services
(Emanuel et al., 2004). While prior studies deal almost
exclusively with adult informed consent, pediatric
assent is likely to be complicated by the same issues.
Furthermore, individual countries are likely to have spe-
cific social and cultural factors influencing pediatric
assent. 
With regard to Kenya, certain social and cultural
characteristics define the rights and status of children,
shape the perception and understanding of informed
consent generally, and determine the view of clinical
research. These culturally specific characteristics could
impinge on the ability to obtain ethical, legitimate pedi-
atric assent within the Kenyan research setting. 
The traditional cultural and social understanding of
children in Kenya is unlikely to include a conception of
the child as an independent agent. According to the
ethnographic literature, people living in indigenous
communities in Western Kenya are considered first and
foremost as parts of a social group, rather than as inde-
pendent agents with autonomy to make their own deci-
sions (Dickerson-Putman & Brown, 1998; Lijembe,
1969; Oboler, 1985; Weisner, 1997; Ember & Ember,
2003). Even individual health-related behaviors, such as
daily medication adherence and child care, are sig-
nificantly affected by community perceptions and the
cultural context (Vreeman et al., 2008). Adults are tradi-
tionally given the decision-making role within the pre-
dominant ethnic groups in Western Kenya, while the
children are expected to show obedience and respect
to their elders by carrying out the adults’ decisions
(Lijembe, 1969; Oboler, 1985). If children do not do as
they are told or are not considered respectful, they can
expect to be beaten (Pinheiro, 2005). However, this con-
ception of the child may be changing (Weisner, Bradley,
& Kilbride,1997). Anecdotally, members of the Kenyan
investigative team and the MU IREC suggested that,
with education becoming more prevalent and more
children being raised in urban centers, children may be
more apt to ask their parents questions regarding their
health and to raise concerns. In particular, increases in
the education and literacy levels of adults and children
alike were thought to be progressively altering the con-
ception of a child into a conception more similar to the
“Western” view.
Children in Western Kenya also may be viewed as an
important resource or as property (Lijembe, 1969;
Oboler, 1985). They are expected to fulfill the responsi-
bilities assigned by their parents, including childcare or
farm work (Oboler, 1985). Among the Nandi, it is even
common for children to be fostered out temporarily to
other family members who may need a child to help
around the house or with the herds and farm. Extended
families in Western Kenya thus share in the manage-
ment, care, and support of children in what is termed
a shared management family system (Oboler, 1985).
Moreover, there are traditional gender differences in
the view of and perceived value of children in Western
Kenya. Female children may be more likely to be
viewed as property (Oboler, 1985, Halperin, 2005).
These dynamics of the family system and the per-
ceived roles of children in Kenya could have important
implications for achieving pediatric assent. The tradi-
tions of both shared management of the family and
group decision making make the concept of individual
consent unusual, particularly for children. If there is a
lifelong expectation that children will quietly and
respectfully comply with adults’ decisions, the children
may be unlikely to voice meaningful dissent. The rou-
tine use of corporal punishment could make children
fear physical harm if they do not give the same answer
as the adults responsible for them, regardless of what
verbal assurances they may receive. The expectation
that children will contribute to the economic stability of
the family could make children vulnerable to participat-
ing in a study because of the expectation of compensa-
tion or of benefits beyond those stated in the study
(Nyambedha, 2008). 
Differences in how and why children of either gender
might be valued could lead to further vulnerabilities for
one gender or the other. Even if procedures are in place to
obtain pediatric assent, a culture of child submissiveness,
Pediatric Assent in Western Kenya 9
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heightened vulnerability in the child’s position within
the household, and parental expectations could all lead
the child to assent despite his or her own objections. For
example, an examination of ethical issues for social sci-
ence research among Kenyan orphans raised concerns
that children were consenting to participation in order to
show respect to adults and because they associated
research with direct assistance for orphans (Nyambedha,
2008). On the other hand, these same vulnerabilities
might compel researchers to attempt to guard the chil-
dren’s safety even more carefully, potentially including
the use of pediatric assent for such purposes.
Previous research has explored community views on
pediatric consent and study participation in Kenya. Of
particular relevance is the perception of children by
community members as competent decision makers,
given the importance of capacity as a criterion for
informed consent. A qualitative study by Molyneux et al.
suggests that children are viewed by the community as
unable to “reason out things” for the purposes of
informed consent and “cannot understand” what the
risks and benefits of a study might be (Molyneux et al.,
2005b). In this context, the child is not seen as a legiti-
mate decision maker, a factor that further undermines
their ability to fully assent or dissent. Children are not
the only agents perceived as lacking the ability to con-
sent in Kenya; community members also suggested that
males should make decisions within the household and
that, in some communities, the women should be allot-
ted the same status as children (e.g., not be considered
capable of consenting) (Molyneux et al., 2005b). 
The informed consent process in Kenya is further
complicated by difficulties in distinguishing research
from health interventions, participation in research
because of expectations of assistance, and the potential
need to incorporate verbal consent. Research on
informed consent from the east coast in Kenya revealed
that consent was based primarily on broad trust in the
institution conducting the research and not on the par-
ticulars of any particular study protocol (Molyneux,
Peshu, & Marsh, 2005a). Furthermore, potential
research subjects may be swayed by the therapeutic mis-
conception in which, despite explanations to the con-
trary, research participants mistakenly believe that the
research project will be of direct benefit to them. While
originally described about research in economically
developed countries (Appelbaum, Roth, and Lidz,
1982), the therapeutic misconception has been
described in other international settings (e.g., Hardy et
al., 1998). The therapeutic misconception can be a
problem in any setting, but it may be a particular con-
cern in settings with less research literacy and poorer
access to health care. With respect to research literacy,
prior studies in Kenya have shown that potential
research subjects experienced this misconception
(Molyneux, Peshu, & Marsh, 2004a). The subjects also
viewed compensation for research participation as an
appreciated assistance (Molyneux et al., 2005b). With
respect to access to care, the National Bioethics
Advisory Commission noted that, in resource-poor
countries, where participation in research may be the
only time when individuals come in contact with a
health care professional, one should be careful about
attaching the label of “misconception”:
[I]t is not a misconception to believe that partici-
pants will probably receive good clinical care during
research. But it is a misconception to believe that the
purpose of clinical trials is to administer treatment
rather than conduct research (NBAC, 2001: 48). 
The expectations of aid in return for research has also
been highlighted as a concern for social science
research within Kenya (Nyambedha, 2008). Moreover,
relying on written informed consent may be considered
less ethical in Kenya than in economically developed
western countries. Our prior experience within the
Indiana University–Moi University collaboration
stressed the need to implement verbal informed consent
(Sidle et al., 2006). Incorporating the already compli-
cated concept of pediatric assent into this informed con-
sent process in Kenya thus requires even greater
attention to these issues.
Working Towards Resolution in the Context 
of a Research Collaboration in Kenya
Emanuel et al. have developed a framework for ethical
clinical research in developing countries that includes
collaborative partnership as a key principle for multina-
tional clinical research (Emanuel et al., 2004). Among
the benchmarks for this principle is respect for the com-
munity’s values, culture, traditions, and social practices.
Respect for the community’s values, culture, and tradi-
tion was also highlighted as a key concern for members
of both the IUPUI IRB and the MU IREC (Sidle et al.,
2006). As highlighted within the case presented, institu-
tional research ethics committees may advocate different
requirements for pediatric assent, reflecting both the
general, substantial challenges with conceptualizing
pediatric assent and specific community values and cul-
tural factors related to the view of children. Nonetheless,
a respectful collaborative partnership engages with the
involved communities to resolve apparent conflicts and
to maximize the ethical conduct of research (Sidle et al.,
10 R. Vreeman, W. Nyandiko, E. Meslin
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2006) In the quest to balance respect for the commu-
nity’s values and culture with national and the protection
of and respect for the child intended by pediatric assent,
community engagement also presents the way forward.
One step in engaging the involved community is to
consult directly with the local institutional research
ethics committee. This is consistent with the expectation
that the responsibility for implementing a pediatric
assent process generally rests with the local IRB (Ungar
et al., 2006). In our particular case, we found that mem-
bers of the MU IREC had widely varying attitudes
toward pediatric assent. Some members were reportedly
in favor of obtaining pediatric assent and viewed obtain-
ing children’s assent as an outgrowth of the Children’s
Act, which stresses children’s rights (Laws of Kenya,
CAP 586), or as a concept congruent with international
standards. These members felt that implementing
pediatric assent practices would be an appropriate step
within the current cultural context. Others felt that
pediatric assent would not be appropriate in this setting
since “our children are brought up to go by their par-
ents’ decision.” Members disagreed among themselves
about the appropriate age cut-off, with some members
agreeing that seven years was an appropriate age at
which to expect the child to “have cognition” and others
feeling an older age would be more appropriate. Some
MU IREC members felt that pediatric assent should
only apply for children without living biological parents,
based on the presumption that parents act in the best
interest of their children, whereas orphans may require
special safeguards. 
Collaboration and Consensus
Reaching consensus on the implementation of our study
procedures also required discussion on the part of our
study team of Kenyan and American investigators.
Although our team had some hesitations, we had
decided to put forward a protocol that would include a
component of pediatric assent. Using a template for
pediatric assent from the IUPUI IRB, we drafted a ver-
sion of a pediatric assent form for the study in English,
which was subsequently translated into Kiswahili
(Figure 2). For children ages seven years and older, we
proposed to have the Kiswahili assent form read aloud
to them by the study research assistant in the presence
of a witness and the research assistant. Children’s verbal
assent or dissent was then signified on the assent form
by having the two witnesses sign the form. We defined
dissent as either verbal dissent at the time of this proce-
dure or the child saying at any future point that they did
not want to participate in the study. 
Following these discussions, the MU IREC ultimately
voted to approve the protocol, including procedures to
obtain verbal pediatric assent for children seven years of
age and older, with a motion made that pediatric assent
needed more discussion. This manuscript was drafted
as part of that continued discussion. Despite our deci-
sions for this protocol, several questions remained, and
other solutions could have been considered. The use of
seven years as a threshold and the ability for a child to
assent or dissent validly in this social context continues to
be debated among the investigators. Would these con-
cerns undermine the legitimacy of pediatric assent in
this particular setting? If so, a different conceptualization
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While you are in the hospital overnight, these are the things we
will ask you to do:
• Take your usual medicines.
• Have an IV line fixed in your arm. The nurse or doctor will
poke a needle into your arm in order to put the IV into one of
your veins. A small tube will stay in the vein in your arm while
you are in the hospital.  
• From this IV tube, we will take out five small blood samples
that will be tested to see how your medicines are working in
your body. We will also take one sample of blood that we will
save in case we want to use it for another test.
• You will need to drink a small amount of medicine that is
mixed with water or juice.
• You will have an exam by a doctor where they examine your
body from head to toe—just like the doctor does when you
usually come to the clinic.
• You will have your height and weight measured on the scale.
• If you take your medicines by yourself, someone who works
for the study will ask you questions about what it is like to
take these medicines.
Mukiwa hospitalini usiku kucha, yafuatayo ni mambo ambayo
tutakuliza wewe ufanye:
• Kuywa/kumeza dawa zako za kawaida.
• Shindano ya mshipa itawekwa kwa mkono wako. Daktari au
muuguzi atadunga shindano kwa mkono wako ili tuweke hii
shindano ya mshipa kwa moja ya vena yako. Tyubu ndogo
itabaki kwa vena ya mkono wako wakati uko hospitalini.
• Toka kwa tyubu hii, tutachukua sampuli ndogo tano za damu
ambazo zitapimwa kuona jinsi dawa zinafanya kazi kwa mwili
wako. Tutachukua sampuli ingine moja ya damu ambayo
tutahifadhi ikiwa tunataka kutumia kwa kuima kwingine.
• Utahitaji kukunywa kiasi kidogo cha dawa ambayo imechangan-
ishwa na juisi au maji.
• Utachunguzwa na daktari ambaye atachunguza mwili wako
kutoka kwa kichwa mpaka kwa kidole cha mguu wako—jinsi
vile daktari hufanya unapokuja kliniki.
• Urefu wako na uzito utapimwa kwa ratili.
• Ukikunywa madawa wewe mwenyewe, mtu anayefanya kazi
kwa uchunguzi huu atakuuliza maswali kuhusu jinsi ilivyo
kukunywa/kumeza madawa haya.
FIG. 2. Excerpt from Pediatric Assent Document in English and in
Kiswahili.
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of pediatric assent, or even waiving pediatric assent
could have been considered (and, arguably, defensible
within U.S. regulations). Furthermore, is there a need to
define more specifically a particular family’s view of and
treatment the child and to tailor the assent process to
that view, or should a universal assent process be
adapted for the study regardless of education level, lan-
guage abilities, or view of the child? Another solution
would have been to argue that pediatric assent could be
waived due to the prospect of direct benefits to enrolled
subjects that were not available outside of the research
context (Wendler, 2006). Given that the Kenyan guide-
lines emphasize respect for a child’s refusal, we also
question how to define this refusal. Would nonverbal
acts of refusal such as crying or unhappiness with a
blood draw necessitate the removal of children from
the study? And was the Kiswahili translation enough
or should we investigate in which language the child
thinks and try to assess assent in that language?
Continuing to evaluate these issues and this experience
remain important priorities as the research collabora-
tion moves forward. 
Summary
We presented a case in which an international research
collaboration grappled with implementing pediatric
assent for a clinical research project in a new context,
specifically within an HIV care system in the low-
income country of Kenya. A careful consideration of this
case raises important points for both the specific issue of
implementing pediatric assent procedures across cul-
tures and for the broader challenge of reaching consen-
sus on the implementation of ethical procedures within
an international research collaboration. We considered
the breadth of accepted pediatric assent practices, the
various recommendations from bodies of oversight,
developmental considerations specific to the vulnerable
population of children, and the specific cultural context
in which our research would take place. The broader
challenges for an international research collaboration
remain—to find consensus through honest engagement
and discussion.
Best Practices
Respect for the independence of the institutional ethics
review committees requires continued commitment to
collaboration and communication, particularly when
resolution is needed for a given ethical dilemma.
Although it is challenging to specify how such resolu-
tion should take place, the process followed in this
analysis of pediatric assent provides one potential model
of best practices: examining relevant national and inter-
national guidelines, considering the local and general
ethical challenges, and then engaging in open dialogue
with community members, investigators, and institu-
tional ethics review committee members might lead to
consensus or other resolution. Moreover, even in the
face of an imperfect system for truly informed consent
for pediatric research, or perhaps because of these limi-
tations (Kodish, 2003), investigators considering bio-
medical research involving children must maintain
heightened awareness of their responsibility to protect
this vulnerable population.  
We also recommend four specific steps to move
towards best practices in implementing pediatric assent
in international research collaborations. First, we urge
consideration of obtaining witnessed verbal consent
or assent in settings with varying degrees of literacy.
Second, study explanations and consent procedures
should be carried out, whenever possible, in the pri-
mary language of the child and the parents, or every
effort should be made to utilize appropriate translators.
Third, research collaborations should develop stan-
dardized, pretested materials to describe common pedi-
atric study procedures such as blood draws. These
materials should be developed and tested for face valid-
ity and comprehension among adult and child commu-
nity members. In our experience, the key components
for the materials for pediatric assent were a simple
description of what would take place and explanations
that the child’s assent was sought, but not required. In
contrast, the adult informed consent materials focused
more on weighing the particulars of the potential risks
and benefits involved. However, continued assessment of
culturally appropriate materials is highly encouraged. In
addition, these materials should be available in the com-
mon languages spoken within the clinic population. For
verbal consent procedures, these materials should be
read aloud to the participants, with ample opportunity
for questions and answers. Finally, the age thresholds for
which assent and consent procedures will be imple-
mented merit continued discussion and investigation.
Research Agenda
Our experience highlights several areas in which addi-
tional research could increase the capacity to conduct
ethical research in children. Specific areas of research
inquiry previously mentioned include investigating the
face validity and reliability of tools to elicit pediatric
assent and caregiver consent, as well as investigation
into age-specific comprehension. We also need to
12 R. Vreeman, W. Nyandiko, E. Meslin
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increase community involvement to assess community
understanding of informed consent and of pediatric
assent. Community involvement will guide efforts to
identify and respond to issues related to informed con-
sent (Gikonyo et al., 2008), but it should go hand-in-hand
with in-depth study of the community’s view of children’s
rights and decision-making capacity. Qualitative research
methods should be used to ascertain a particular com-
munity’s beliefs about children and assent. An addi-
tional research step might be to evaluate the impact of a
U.S. designation of “equivalent protection” given to Moi’s
institutional guidelines, as has been proposed for other
countries (Lavery et al., 2005). This is a regulatory des-
ignation that recognizes another institutions’ ethics
review guidelines and being substantially equivalent to
those in the U.S. Having “equivalent status” in our col-
laboration in Kenya would mean that protocols could
be reviewed only by the MU IREC, and not require an
additional review by the IUPUI IRB. This would not
eliminate the need for careful, deliberate dialogue about
challenging issues, but we could evaluate whether this
strategy leads to the implementation of more culturally
sensitive strategies to meet ethical standards. Another
option would be to evaluate the functioning of an “inter-
national” collaborating ethics review board that
included members from all of the collaborating
research partners.
Educational Implications
This consideration of pediatric assent in an international
research collaboration has several educational implica-
tions. First, the research program must ensure that
investigators from all parts of the collaboration who
want to conduct research in children first receive spe-
cific training in the ethics of pediatric research. Ideally,
this education would occur collaboratively and would
enable enhanced understanding of the particular vul-
nerabilities of pediatric research participants, as well as
the culturally specific views related to children. Second,
because of the novelty of implementing pediatric assent
in this cultural setting and because of the ways that
pediatric assent could conflict with the parent’s or
guardian’s usual view of the child, we need specific edu-
cation for study personnel related to pediatric assent
and caregiver consent. This education should empha-
size that open-ended questions and probes must accom-
pany the use of consent forms or documents to better
evaluate understanding, fears, and relational dynamics
within the family—all of which could impinge on the
ability of even the older child to provide assent. Finally,
we need to champion increased community involvement
in order to learn directly how to best respect the rights
of children within this particular setting. Better under-
standing the community’s view of children and family
units, in addition to understanding the community’s
conception of informed consent, will enable us to best
identify and respond to challenges to protecting the
vulnerable pediatric population within the research
context.
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